She died at John Hunter Hospital yesterday after developing blood clots.
9News can confirm the woman was not a frontline health worker, but her medical issues put her in the 1B rollout category.
The woman, who was diabetic, had serious underlying health issues before receiving the vaccine.
Her cause of death, and any connection between it, the blood clots, and the vaccine, is yet to be determined, with health authorities currently investigating.
NSW Premier Gladys Berejiklian this morning offered her sympathies to the woman’s family as she waits for advice from health authorities.
“In the meantime we just extend our heartfelt condolences to the family and loved ones during this difficult time,” she told Today.
The Therapeutic Goods Administration has said it is seeking “further clinical information including clinical test results” from the NSW Health Department.
Ms Berejiklian said she believed the “vast majority” of citizens wanted to get a vaccine, despite the highly-publicised incidences of rare adverse reactions.
“It is important for us to be really well-advised,” she said.
“If anyone has concerns, you should ask your GP.”
She also called on the federal government to provide more doses to the states.
“(State governments) are ready to help provide the vaccine to our citizens,” she said.
“It wasn’t in the plans for the states to do more than what we are currently doing but I think it is important for us to step up and support the vaccine roll-out, but we can’t really get those supplies.
“That’s a matter for the Commonwealth to get the vaccines themselves and source those vaccines and once they are available to us we will make sure they are available to our citizens.”
The federal government has said it no longer recommended people under 50 get AstraZeneca vaccines.
“The blood clotting disorders being investigated in connection with the AstraZeneca COVID-19 vaccine are very rare and differ from common blood clots or venous thromboembolism, which occur in around 50 Australians every day,” the TGA said.
“The clotting disorder being investigated in connection with the AstraZeneca COVID-19 vaccine, which is now referred to as ‘thrombosis with thrombocytopenia syndrome’ (TTS), has been confirmed in only two cases out of over 700,000 people who have received the AstraZeneca vaccine in Australia.”
Medical authorities stress that the blood clots remain extremely rare in vaccine recipients, about about “four to six, per million doses of vaccine”, according to the Chief Health Officer last week.
“NSW Health does not speculate on or discuss individual cases, but the death of anyone is always a tragedy and our condolences are with the family and loved ones of the person who has passed away,” the NSW Health Department said in a statement.
“An adverse event following immunisation is any untoward medical event that occurs after a vaccination has been given, which may be related to the vaccine.
“A conclusion regarding a causal relationship with the vaccine is not necessary to suspect or report an adverse event.
“Many conditions can arise during normal life, whether or not a vaccine is administered, but it remains important to report any new serious or unexpected events so that safety can be appropriately monitored.”
Prime Minister Scott Morrison cautioned against jumping to conclusions, saying “I think there’s a lot more to understand and learn about that issue.”
“I think it’s important because of the fact that people can have concerns that we follow that important process to inform ourselves properly, to allow those medical experts to make their enquiries and to be able to inform government in an appropriate way,” he said.
“And so for us not to move to any conclusions at this point what’s important is that we continue on with the project and we’ll certainly do that.
“And we’ve been very transparent, very transparent when it comes to information on these issues.”
As of the latest update, 164,855 vaccinations for coronavirus have been administered in NSW.
Source: 9News | World News